Global Tuberculosis Prevention and Treatment Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 100

Published Date: 09 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.

According to our (Global Info Research) latest study, the global Tuberculosis Prevention and Treatment Vaccine market size was valued at USD 76 million in 2022 and is forecast to a readjusted size of USD 102.9 million by 2029 with a CAGR of 4.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.

The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.

Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.

Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.

This report is a detailed and comprehensive analysis for global Tuberculosis Prevention and Treatment Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Tuberculosis Prevention and Treatment Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Tuberculosis Prevention and Treatment Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Tuberculosis Prevention and Treatment Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Tuberculosis Prevention and Treatment Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tuberculosis Prevention and Treatment Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tuberculosis Prevention and Treatment Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines and BioFarma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Tuberculosis Prevention and Treatment Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Immune Vaccine
    Therapy Vaccine

Market segment by Application
    Self-Procurement
    UNICEF
    Other

Major players covered
    Merck
    Japan BCG Lab
    Serum Institute of India
    AJ Vaccines
    BioFarma
    GreenSignal Bio Pharma
    China National Biotec
    Biomed Lublin
    Taj Pharmaceuticals
    Ataulpho de Paiva
    IVAC
    Queen Saovabha Mem. Inst
    Microgen

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tuberculosis Prevention and Treatment Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tuberculosis Prevention and Treatment Vaccine, with price, sales, revenue and global market share of Tuberculosis Prevention and Treatment Vaccine from 2018 to 2023.
Chapter 3, the Tuberculosis Prevention and Treatment Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tuberculosis Prevention and Treatment Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tuberculosis Prevention and Treatment Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tuberculosis Prevention and Treatment Vaccine.
Chapter 14 and 15, to describe Tuberculosis Prevention and Treatment Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Tuberculosis Prevention and Treatment Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Immune Vaccine
        1.3.3 Therapy Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Self-Procurement
        1.4.3 UNICEF
        1.4.4 Other
    1.5 Global Tuberculosis Prevention and Treatment Vaccine Market Size & Forecast
        1.5.1 Global Tuberculosis Prevention and Treatment Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Tuberculosis Prevention and Treatment Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Merck
        2.1.1 Merck Details
        2.1.2 Merck Major Business
        2.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.1.4 Merck Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Merck Recent Developments/Updates
    2.2 Japan BCG Lab
        2.2.1 Japan BCG Lab Details
        2.2.2 Japan BCG Lab Major Business
        2.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.2.4 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Japan BCG Lab Recent Developments/Updates
    2.3 Serum Institute of India
        2.3.1 Serum Institute of India Details
        2.3.2 Serum Institute of India Major Business
        2.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.3.4 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Serum Institute of India Recent Developments/Updates
    2.4 AJ Vaccines
        2.4.1 AJ Vaccines Details
        2.4.2 AJ Vaccines Major Business
        2.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.4.4 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 AJ Vaccines Recent Developments/Updates
    2.5 BioFarma
        2.5.1 BioFarma Details
        2.5.2 BioFarma Major Business
        2.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.5.4 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 BioFarma Recent Developments/Updates
    2.6 GreenSignal Bio Pharma
        2.6.1 GreenSignal Bio Pharma Details
        2.6.2 GreenSignal Bio Pharma Major Business
        2.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.6.4 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 GreenSignal Bio Pharma Recent Developments/Updates
    2.7 China National Biotec
        2.7.1 China National Biotec Details
        2.7.2 China National Biotec Major Business
        2.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.7.4 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 China National Biotec Recent Developments/Updates
    2.8 Biomed Lublin
        2.8.1 Biomed Lublin Details
        2.8.2 Biomed Lublin Major Business
        2.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.8.4 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Biomed Lublin Recent Developments/Updates
    2.9 Taj Pharmaceuticals
        2.9.1 Taj Pharmaceuticals Details
        2.9.2 Taj Pharmaceuticals Major Business
        2.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.9.4 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Taj Pharmaceuticals Recent Developments/Updates
    2.10 Ataulpho de Paiva
        2.10.1 Ataulpho de Paiva Details
        2.10.2 Ataulpho de Paiva Major Business
        2.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.10.4 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Ataulpho de Paiva Recent Developments/Updates
    2.11 IVAC
        2.11.1 IVAC Details
        2.11.2 IVAC Major Business
        2.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.11.4 IVAC Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 IVAC Recent Developments/Updates
    2.12 Queen Saovabha Mem. Inst
        2.12.1 Queen Saovabha Mem. Inst Details
        2.12.2 Queen Saovabha Mem. Inst Major Business
        2.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.12.4 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
    2.13 Microgen
        2.13.1 Microgen Details
        2.13.2 Microgen Major Business
        2.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Product and Services
        2.13.4 Microgen Tuberculosis Prevention and Treatment Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Microgen Recent Developments/Updates

3 Competitive Environment: Tuberculosis Prevention and Treatment Vaccine by Manufacturer
    3.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Tuberculosis Prevention and Treatment Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Tuberculosis Prevention and Treatment Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Tuberculosis Prevention and Treatment Vaccine Manufacturer Market Share in 2022
    3.5 Tuberculosis Prevention and Treatment Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Tuberculosis Prevention and Treatment Vaccine Market: Region Footprint
        3.5.2 Tuberculosis Prevention and Treatment Vaccine Market: Company Product Type Footprint
        3.5.3 Tuberculosis Prevention and Treatment Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region
        4.1.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Region (2018-2029)
    4.2 North America Tuberculosis Prevention and Treatment Vaccine Consumption Value (2018-2029)
    4.3 Europe Tuberculosis Prevention and Treatment Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Consumption Value (2018-2029)
    4.5 South America Tuberculosis Prevention and Treatment Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Application (2018-2029)
    6.3 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America Tuberculosis Prevention and Treatment Vaccine Market Size by Country
        7.3.1 North America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Tuberculosis Prevention and Treatment Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe Tuberculosis Prevention and Treatment Vaccine Market Size by Country
        8.3.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Tuberculosis Prevention and Treatment Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Market Size by Region
        9.3.1 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America Tuberculosis Prevention and Treatment Vaccine Market Size by Country
        10.3.1 South America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Tuberculosis Prevention and Treatment Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Market Size by Country
        11.3.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Tuberculosis Prevention and Treatment Vaccine Market Drivers
    12.2 Tuberculosis Prevention and Treatment Vaccine Market Restraints
    12.3 Tuberculosis Prevention and Treatment Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Tuberculosis Prevention and Treatment Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Tuberculosis Prevention and Treatment Vaccine
    13.3 Tuberculosis Prevention and Treatment Vaccine Production Process
    13.4 Tuberculosis Prevention and Treatment Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Tuberculosis Prevention and Treatment Vaccine Typical Distributors
    14.3 Tuberculosis Prevention and Treatment Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Merck Basic Information, Manufacturing Base and Competitors
    Table 4. Merck Major Business
    Table 5. Merck Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 6. Merck Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Merck Recent Developments/Updates
    Table 8. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
    Table 9. Japan BCG Lab Major Business
    Table 10. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 11. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Japan BCG Lab Recent Developments/Updates
    Table 13. Serum Institute of India Basic Information, Manufacturing Base and Competitors
    Table 14. Serum Institute of India Major Business
    Table 15. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 16. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Serum Institute of India Recent Developments/Updates
    Table 18. AJ Vaccines Basic Information, Manufacturing Base and Competitors
    Table 19. AJ Vaccines Major Business
    Table 20. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 21. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. AJ Vaccines Recent Developments/Updates
    Table 23. BioFarma Basic Information, Manufacturing Base and Competitors
    Table 24. BioFarma Major Business
    Table 25. BioFarma Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 26. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. BioFarma Recent Developments/Updates
    Table 28. GreenSignal Bio Pharma Basic Information, Manufacturing Base and Competitors
    Table 29. GreenSignal Bio Pharma Major Business
    Table 30. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 31. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. GreenSignal Bio Pharma Recent Developments/Updates
    Table 33. China National Biotec Basic Information, Manufacturing Base and Competitors
    Table 34. China National Biotec Major Business
    Table 35. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 36. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. China National Biotec Recent Developments/Updates
    Table 38. Biomed Lublin Basic Information, Manufacturing Base and Competitors
    Table 39. Biomed Lublin Major Business
    Table 40. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 41. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Biomed Lublin Recent Developments/Updates
    Table 43. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 44. Taj Pharmaceuticals Major Business
    Table 45. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 46. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Taj Pharmaceuticals Recent Developments/Updates
    Table 48. Ataulpho de Paiva Basic Information, Manufacturing Base and Competitors
    Table 49. Ataulpho de Paiva Major Business
    Table 50. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 51. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Ataulpho de Paiva Recent Developments/Updates
    Table 53. IVAC Basic Information, Manufacturing Base and Competitors
    Table 54. IVAC Major Business
    Table 55. IVAC Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 56. IVAC Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. IVAC Recent Developments/Updates
    Table 58. Queen Saovabha Mem. Inst Basic Information, Manufacturing Base and Competitors
    Table 59. Queen Saovabha Mem. Inst Major Business
    Table 60. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 61. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Queen Saovabha Mem. Inst Recent Developments/Updates
    Table 63. Microgen Basic Information, Manufacturing Base and Competitors
    Table 64. Microgen Major Business
    Table 65. Microgen Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 66. Microgen Tuberculosis Prevention and Treatment Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Microgen Recent Developments/Updates
    Table 68. Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 69. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 70. Global Tuberculosis Prevention and Treatment Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 71. Market Position of Manufacturers in Tuberculosis Prevention and Treatment Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 72. Head Office and Tuberculosis Prevention and Treatment Vaccine Production Site of Key Manufacturer
    Table 73. Tuberculosis Prevention and Treatment Vaccine Market: Company Product Type Footprint
    Table 74. Tuberculosis Prevention and Treatment Vaccine Market: Company Product Application Footprint
    Table 75. Tuberculosis Prevention and Treatment Vaccine New Market Entrants and Barriers to Market Entry
    Table 76. Tuberculosis Prevention and Treatment Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 77. Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 78. Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 79. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 80. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 81. Global Tuberculosis Prevention and Treatment Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 82. Global Tuberculosis Prevention and Treatment Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 83. Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 84. Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 85. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 86. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 87. Global Tuberculosis Prevention and Treatment Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 88. Global Tuberculosis Prevention and Treatment Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 89. Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 90. Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 91. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 92. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 93. Global Tuberculosis Prevention and Treatment Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 94. Global Tuberculosis Prevention and Treatment Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 95. North America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 96. North America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 97. North America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 98. North America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 99. North America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 100. North America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 101. North America Tuberculosis Prevention and Treatment Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 102. North America Tuberculosis Prevention and Treatment Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 103. Europe Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 104. Europe Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 105. Europe Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 106. Europe Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 107. Europe Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 108. Europe Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 109. Europe Tuberculosis Prevention and Treatment Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 110. Europe Tuberculosis Prevention and Treatment Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 111. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 112. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 113. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 114. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 115. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 116. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 117. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 118. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 119. South America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 120. South America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 121. South America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 122. South America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 123. South America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 124. South America Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 125. South America Tuberculosis Prevention and Treatment Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 126. South America Tuberculosis Prevention and Treatment Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 127. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 128. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 129. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 130. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 131. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 132. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 133. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 134. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 135. Tuberculosis Prevention and Treatment Vaccine Raw Material
    Table 136. Key Manufacturers of Tuberculosis Prevention and Treatment Vaccine Raw Materials
    Table 137. Tuberculosis Prevention and Treatment Vaccine Typical Distributors
    Table 138. Tuberculosis Prevention and Treatment Vaccine Typical Customers
List of Figures
    Figure 1. Tuberculosis Prevention and Treatment Vaccine Picture
    Figure 2. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Immune Vaccine Examples
    Figure 5. Therapy Vaccine Examples
    Figure 6. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value Market Share by Application in 2022
    Figure 8. Self-Procurement Examples
    Figure 9. UNICEF Examples
    Figure 10. Other Examples
    Figure 11. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity (2018-2029) & (K Units)
    Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 15. Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Tuberculosis Prevention and Treatment Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Tuberculosis Prevention and Treatment Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Tuberculosis Prevention and Treatment Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Tuberculosis Prevention and Treatment Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Tuberculosis Prevention and Treatment Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Tuberculosis Prevention and Treatment Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Tuberculosis Prevention and Treatment Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 30. Global Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Tuberculosis Prevention and Treatment Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Tuberculosis Prevention and Treatment Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 33. North America Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Tuberculosis Prevention and Treatment Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Tuberculosis Prevention and Treatment Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Tuberculosis Prevention and Treatment Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Tuberculosis Prevention and Treatment Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Tuberculosis Prevention and Treatment Vaccine Market Drivers
    Figure 74. Tuberculosis Prevention and Treatment Vaccine Market Restraints
    Figure 75. Tuberculosis Prevention and Treatment Vaccine Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Tuberculosis Prevention and Treatment Vaccine in 2022
    Figure 78. Manufacturing Process Analysis of Tuberculosis Prevention and Treatment Vaccine
    Figure 79. Tuberculosis Prevention and Treatment Vaccine Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen

Related Reports

Global Tuberculosis Prevention and Treatment Vaccine Supply, Demand and Key Producers, 2023-2029

Global Tuberculosis Prevention and Treatment Vaccine Supply, Demand and Key Producers, 2023-2029

date 25 Feb 2023

date Pharma & Healthcare

The global Tuberculosis Prevention and Treatment Vaccine market size is expected to reach $ 102.9 million by 2029, rising at a market growth of 4.4% CAGR during the forecast period (2023-2029).

Global Tuberculosis Prevention and Treatment Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Tuberculosis Prevention and Treatment Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Tuberculosis Prevention and Treatment Vaccine market size was valued at USD 76 million in 2023 and is forecast to a readjusted size of USD 102.9 million by 2030 with a CAGR of 4.4% during review period.

Global Tuberculosis Prevention and Treatment Vaccine Supply, Demand and Key Producers, 2024-2030

Global Tuberculosis Prevention and Treatment Vaccine Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

The global Tuberculosis Prevention and Treatment Vaccine market size is expected to reach $ 102.9 million by 2030, rising at a market growth of 4.4% CAGR during the forecast period (2024-2030).

Product Tags

Tuberculosis Prevention and Treatment Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>